Heart rhythm hope: common diabetes drug tested to stop AFib recurrence

NCT ID NCT07187570

First seen Oct 31, 2025 · Last updated May 16, 2026 · Updated 24 times

Summary

This study tests whether the drug dapagliflozin, typically used for diabetes, can reduce the return of atrial fibrillation (an irregular heartbeat) after a procedure called cardioversion. About 1600 adults with AFib will take either dapagliflozin or no extra drug for up to 56 days. Researchers will track heart rhythms using a handheld device to see if the drug helps keep the heart in normal rhythm.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION (AF) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Akademiska sjukhuset

    NOT_YET_RECRUITING

    Uppsala, 75389, Sweden

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Danderyds Hospital

    NOT_YET_RECRUITING

    Stockholm, 18527, Sweden

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Karolinska University Hospital

    RECRUITING

    Stockholm, 14186, Sweden

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Linköping university hosptial

    NOT_YET_RECRUITING

    Linköping, 58225, Sweden

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Norrlands universitetssjukhus

    NOT_YET_RECRUITING

    Umeå, 90185, Sweden

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Södersjukhuset

    NOT_YET_RECRUITING

    Stockholm, 11861, Sweden

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Örebro University hospital

    RECRUITING

    Örebro, 70382, Sweden

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.